| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 25 |
| 1 | RIBOCICLIB | 25 |
| 2 | ADALIMUMAB | 24 |
| 3 | LETROZOLE | 23 |
| 4 | OMEPRAZOLE | 23 |
| 5 | LETROZOLE TABLETS | 17 |
| 6 | TRASTUZUMAB | 15 |
| 7 | ERGOCALCIFEROL | 13 |
| 8 | QUETIAPINE | 13 |
| 9 | PACLITAXEL | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM MONOFLUOROPHOSPHATE | 1 | 0.0027 |
| 1 | TINIDAZOLE | 1 | 0.0023 |
| 2 | ORPHENADRINE CITRATE | 1 | 0.0016 |
| 3 | DOXYCYCLINE MONOHYDRATE | 2 | 0.0013 |
| 4 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 5 | ADO-TRASTUZUMAB EMTANSINE | 7 | 0.0008 |
| 6 | RIBOCICLIB | 25 | 0.0008 |
| 7 | PRASTERONE | 2 | 0.0007 |
| 8 | POLIDOCANOL | 1 | 0.0007 |
| 9 | ACHILLEA MILLEFOLIUM, ARNICA MONTANA, HYPERICUM PERFORATUM, HORSE CHESTNUT, AND VISCUM ALBUM WHOLE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 40 |
| 1 | Proton Pump Inhibitor [EPC] | 28 |
| 2 | Corticosteroid [EPC] | 25 |
| 3 | Microtubule Inhibitor [EPC] | 22 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 5 | Kinase Inhibitor [EPC] | 17 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 15 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 14 |
| 8 | Provitamin D2 Compound [EPC] | 13 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Nitrofuran Antibacterial [EPC] | 11 | 0.0006 |
| 3 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 4 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 5 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 6 | Aromatase Inhibitor [EPC] | 40 | 0.0004 |
| 7 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 8 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 15 | 0.0002 |